These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 10735946

  • 1. Expression of the inducible isoform of nitric oxide synthase in pigment cell lesions of the skin.
    Ahmed B, Van Den Oord JJ.
    Br J Dermatol; 2000 Mar; 142(3):432-40. PubMed ID: 10735946
    [Abstract] [Full Text] [Related]

  • 2. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [Abstract] [Full Text] [Related]

  • 3. Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin.
    Ahmed B, Van Den Oord JJ.
    Br J Dermatol; 1999 Jul; 141(1):12-9. PubMed ID: 10417510
    [Abstract] [Full Text] [Related]

  • 4. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
    Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M, Stolz W.
    Arch Dermatol Res; 1999 Jul; 291(2-3):81-7. PubMed ID: 10195394
    [Abstract] [Full Text] [Related]

  • 5. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 6. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion.
    Robertson FM, Long BW, Tober KL, Ross MS, Oberyszyn TM.
    Carcinogenesis; 1996 Sep 15; 17(9):2053-9. PubMed ID: 8824534
    [Abstract] [Full Text] [Related]

  • 7. Telomerase activity and expression of apoptosis and anti-apoptosis regulators in the progression pathway of human melanoma.
    Yang P, Becker D.
    Int J Oncol; 2000 Nov 15; 17(5):913-9. PubMed ID: 11029492
    [Abstract] [Full Text] [Related]

  • 8. Expression of neurotrophins and their receptors in pigment cell lesions of the skin.
    Innominato PF, Libbrecht L, van den Oord JJ.
    J Pathol; 2001 May 15; 194(1):95-100. PubMed ID: 11329147
    [Abstract] [Full Text] [Related]

  • 9. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells.
    Ekmekcioglu S, Ellerhorst JA, Mumm JB, Zheng M, Broemeling L, Prieto VG, Stewart AL, Mhashilkar AM, Chada S, Grimm EA.
    Mol Cancer Ther; 2003 Jan 15; 2(1):9-17. PubMed ID: 12533668
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.
    Xie K, Fidler IJ.
    Cancer Metastasis Rev; 1998 Mar 15; 17(1):55-75. PubMed ID: 9544423
    [Abstract] [Full Text] [Related]

  • 12. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
    Hussein MR, Elsers DA, Fadel SA, Omar AE.
    J Clin Pathol; 2006 Mar 15; 59(3):316-24. PubMed ID: 16505286
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of nitric oxide synthases in human scalp epidermal and hair follicle pigmentary units: implications for regulation of melanogenesis.
    Sowden HM, Naseem KM, Tobin DJ.
    Br J Dermatol; 2005 Aug 15; 153(2):301-9. PubMed ID: 16086740
    [Abstract] [Full Text] [Related]

  • 14. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
    Ludwig HC, Ahkavan-Shigari R, Rausch S, Schallock K, Quentin C, Ziegler D, Bockermann V, Markakis E.
    Anticancer Res; 2000 Aug 15; 20(1A):305-10. PubMed ID: 10769672
    [Abstract] [Full Text] [Related]

  • 15. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C.
    Br J Pharmacol; 1996 Feb 15; 117(4):619-32. PubMed ID: 8646406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.
    Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA.
    Clin Cancer Res; 2000 Dec 15; 6(12):4768-75. PubMed ID: 11156233
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ.
    Br J Pharmacol; 1996 Aug 15; 118(7):1659-68. PubMed ID: 8842429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T.
    Cancer Res; 2001 Oct 01; 61(19):7305-9. PubMed ID: 11585770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.